Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails

Journal of Alzheimer's Disease

Volumn 53, Issue 2, 2016, Pages 419-444

  Landel, Véréna ^a   Annweiler, Cédric ^b,c   Millet, Pascal ^a,d   Morello, Maria ^a,e,f   Féron, François ^a   Wion, Didier ^g  

^a Mediterranée University   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d HÔPITAL FERNAND WIDAL   (France)

^e TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g NONE

Author keywords

Alzheimer's disease; Clinical trials; Cognitive function; Vitamin D

Indexed keywords

AMYLOID; VITAMIN D;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOGENESIS; BLOOD VESSEL; BRAIN; CALCIUM HOMEOSTASIS; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE AGING; COGNITIVE DEFECT; DRUG MECHANISM; ENERGY METABOLISM; EPISODIC MEMORY; EXECUTIVE FUNCTION; GENETIC BACKGROUND; HUMAN; INFLAMMATION; META ANALYSIS (TOPIC); NERVOUS SYSTEM FUNCTION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; REVIEW; SEX DIFFERENCE; SYNAPTIC TRANSMISSION; SYSTEMATIC REVIEW (TOPIC); VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; ANIMAL; COMPLICATION; DIETARY SUPPLEMENT; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; COGNITION DISORDERS; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84979210893     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150943     Document Type: Review

References (143)

1. Hess AF (1924) On the induction of antirachitic properties in rations by exposure to light. Science 60, 269.
2. Hume EM, Smith HH (1924) The effect of irradiation of the environment with ultra-violet light upon the growth and calcification of rats, fed on a diet deficient in fatsoluble vitamins. The part played by irradiated sawdust. Biochem J 18, 1334-1348.
3. Steenbock H (1924) The induction of growth promoting and calcifying properties in a ration by exposure to light. Science 60, 224-225.
4. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW (1972) The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43, 413-431.
5. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, HewisonM(2014)VitaminDand DBP: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144(Pt A), 132-137.
6. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507-515.
7. Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF (2013) Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab 98, 973-979.
8. HolickMF, Biancuzzo RM, Chen TC, Klein EK,Young A, Bibuld D, Reitz R, SalamehW, Ameri A, TannenbaumAD (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93, 677-681.
9. Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, Chope G, Hypponen E, Berry J, Vieth R, Lanham-New S (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis. Am J Clin Nutr 95, 1357-1364.
10. Lehmann U, Hirche F, Stangl GI, Hinz K, Westphal S, Dierkes J (2013) Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial. J Clin Endocrinol Metab 98, 4339-4345.
11. Swanson CM, Nielson CM, Shrestha S, Lee CG, Barrett-Connor E, Jans I, Cauley JA, Boonen S, Bouillon R, Vanderschueren D, Orwoll ES (2014) Higher 25(OH)D2 is associated with lower 25(OH)D3 and 1,25(OH)2D3. J Clin Endocrinol Metab 99, 2736-2744.
12. Haussler MR, Jurutka PW, Mizwicki M, Norman AW (2011) Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): Genomic and nongenomic mechanisms. Best Pract Res Clin Endocrinol Metab 25, 543-559.
13. Hii CS, Ferrante A (2016) The non-genomic actions of vitamin D. Nutrients 8, pii: E135.
14. Ross AC,Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 Dietary Reference Intakes for Calcium and Vitamin D: What dietetics practitioners need to know. J Am Diet Assoc 111, 524-527.
15. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
16. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930.
17. Mazahery H, von Hurst PR (2015) Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients 7, 5111-5142.
18. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R (2013)Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369, 1991-2000.
19. Palacios C and Lilliana G (2014) Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol 144, 138-145.
20. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K (2014) A systematic review of vitamin D status in populations worldwide. Br J Nutr 111, 23-45.
21. Fardellone P, Sebert JL, Garabedian M, Bellony R, Maamer M, Agbomson F, Brazier M (1995) Prevalence and biological consequences of vitamin D deficiency in elderly institutionalized subjects. Rev Rhum Engl Ed 62, 576-581.
22. HolickMF,MatsuokaLY,Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet 2, 1104-1105.
23. MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76, 1536-1538.
24. Pines A (2014) Vitamin D and health issues-questioned benefits. Climacteric 17, 657-659.
25. Rush L, McCartney G, Walsh D, MacKay D (2013) Vitamin D and subsequent all-age and premature mortality: A systematic review. BMC Public Health 13, 679.
26. Kumar A, Singh A, Ekavali (2015) A review on Alzheimer's disease pathophysiology and its management: An update. Pharmacol Rep 67, 195-203.
27. Zhang F, Jiang L (2015) Neuroinflammation in Alzheimer's disease. Neuropsychiatr Dis Treat 11, 243-256.
28. Prince M, Bryce R, Albanese E,Wimo A, RibeiroW, Ferri CP (2013) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 9, 63-75 e62.
29. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR (1992) Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: Correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 13, 239-250.
30. Gezen-Ak D, Dursun E, Bilgic B, Hanagasi H, Ertan T, Gurvit H, Emre M, Eker E, Ulutin T, Uysal O, Yilmazer S (2012) Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med 228, 189-196.
31. Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, Eker E, Ozturk M, Engin F, Yilmazer S (2007) Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 212, 275-282.
32. Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RG, van Heemst D (2009) VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 30, 466-473.
33. Lehmann DJ, Refsum H,Warden DR,Medway C,Wilcock GK, Smith AD (2011) The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci Lett 504, 79-82.
34. Laczmanski L, Jakubik M, Bednarek-Tupikowska G, Rymaszewska J, Sloka N, Lwow F (2015) Vitamin D receptor gene polymorphisms in Alzheimer's disease patients. Exp Gerontol 69, 142-147.
35. Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, Gallins PJ, Whitehead PL, Wang G, Lu C, Slifer MA, Zuchner S, Martin ER, Mash D, Haines JL, Pericak-Vance MA, Gilbert JR (2012) Vitamin D receptor and Alzheimer's disease: A genetic and functional study. Neurobiol Aging 33, 1844 e1841-1849.
36. Beydoun MA, Ding EL, Beydoun HA, Tanaka T, Ferrucci L, Zonderman AB (2012) Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 95, 163-178.
37. DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, EbersGC(2013) Review: The role of vitaminDin nervous system health and disease. Neuropathol Appl Neurobiol 39, 458-484.
38. Garcion E,Wion-Barbot N, Montero-Menei CN, Berger F, WionD(2002) Newclues about vitaminDfunctions in the nervous system. Trends Endocrinol Metab 13, 100-105.
39. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alphahydroxylase in human brain. J Chem Neuroanat 29, 21-30.
40. Stumpf WE, O'Brien LP (1987) 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 87, 393-406.
41. Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P (1991) 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28, 110-114.
42. Eyles DW, Liu PY, Josh P, Cui X (2014) Intracellular distribution of the vitamin D receptor in the brain: Comparison with classic target tissues and redistribution with development. Neuroscience 268, 1-9.
43. Balabanova S, RichterHP, Antoniadis G, Homoki J, Kremmer N, Hanle J, Teller WM(1984) 25-Hydroxy vitamin D, 24, 25-di hydroxy vitamin D and 1,25-di hydroxy vitamin D in human cerebrospinal fluid. Klin Wochenschr 62, 1086-1090.
44. Naveilhan P, Neveu I, Baudet C, Ohyama KY, Brachet P, Wion D (1993) Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells. Neuroreport 5, 255-257.
45. Neveu I, Naveilhan P, Baudet C, Brachet P, Metsis M (1994) 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 6, 124-126.
46. Neveu I,Naveilhan P, Jehan F, Baudet C,Wion D, De Luca HF, Brachet P (1994) 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 24, 70-76.
47. Dursun E, Gezen-Ak D, Yilmazer S (2013) Beta amyloid suppresses the expression of the vitamin d receptor gene and induces the expression of the vitamin d catabolic enzyme gene in hippocampal neurons. Dement Geriatr Cogn Disord 36, 76-86.
48. Gezen-Ak D, Dursun E, Yilmazer S (2011) The effects of vitamin D receptor silencing on the expression of LVSCCA1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS One 6, e17553.
49. Gezen-Ak D, Dursun E, Yilmazer S (2013) Vitamin D inquiry in hippocampal neurons: Consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurol Sci 34, 1453-1458.
50. Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, Nakamichi N, Yoneda Y (2006) Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 83, 1179-1189.
51. Baas D, Prufer K, Ittel ME, Kuchler-Bopp S, Labourdette G, Sarlieve LL, Brachet P (2000) Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 31, 59-68.
52. Durk MR, Chan GN, Campos CR, Peart JC, Chow EC, Lee E, Cannon RE, Bendayan R, Miller DS, Pang KS (2012) 1alpha,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells. J Neurochem 123, 944-953.
53. Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T (2011) 1alpha,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-beta peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 8, 20.
54. Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A (1998) Vitamin D metabolism and action. Osteoporos Int 8(Suppl 2), S13-S19.
55. Cornet A, Baudet C, Neveu I, Baron-Van Evercooren A, Brachet P, Naveilhan P (1998) 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res 53, 742-746.
56. Naveilhan P, Neveu I, Baudet C, Funakoshi H, Wion D, Brachet P, Metsis M (1996) 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Brain Res Mol Brain Res 41, 259-268.
57. Gezen-Ak D, Yilmazer S, Dursun E (2014) Why vitamin D in Alzheimer's disease? The hypothesis. J Alzheimers Dis 40, 257-269.
58. Keisala T, Minasyan A, Lou YR, Zou J, Kalueff AV, Pyykko I, Tuohimaa P (2009) Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 115, 91-97.
59. Latimer CS, Brewer LD, Searcy JL, Chen KC, Popovic J, Kraner SD, Thibault O, Blalock EM, Landfield PW, Porter NM (2014) Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A 111, E4359-4366.
60. Briones TL, Darwish H (2012) Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. J Neuroinflammation 9, 244.
61. Briones TL, Darwish H (2014) Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state. Neuroscience 262, 143-155.
62. Taghizadeh M, Djazayery A, Salami M, Eshraghian MR, Zavareh SA (2011) Vitamin-D-free regimen intensifies the spatial learning deficit in Alzheimer's disease. Int J Neurosci 121, 16-24.
63. Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS (2011) Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AbetaPP transgenic mice. J Alzheimers Dis 25, 295-307.
64. Landel V, Millet P, Baranger K, Loriod B, Feron F (2016) Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease. Mol Neurodegener 11, 22.
65. Durk MR, Han K, Chow EC, Ahrens R, Henderson JT, Fraser PE, Pang KS (2014) 1alpha,25-Dihydroxyvitamin D3 reduces cerebral amyloid-beta accumulation and improves cognition in mouse models of Alzheimer's disease. J Neurosci 34, 7091-7101.
66. Bennett L, Kersaitis C, Macaulay SL, Munch G, Niedermayer G, Nigro J, Payne M, Sheean P, Vallotton P, Zabaras D, Bird M (2013) Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice. PLoS One 8, e76362.
67. Grimm MO, Lehmann J, Mett J, Zimmer VC, Grosgen S, Stahlmann CP, Hundsdorfer B, Haupenthal VJ, Rothhaar TL, Herr C, Bals R, Grimm HS, HartmannT(2014) Impact of Vitamin D on amyloid precursor protein processing and amyloid-beta peptide degradation in Alzheimer's disease. Neurodegener Dis 13, 75-81.
68. Moon M, Song H, Hong HJ, Nam DW, Cha MY, Oh MS, Yu J, Ryu H, Mook-Jung I (2013) Vitamin D-binding protein interacts with Abeta and suppresses Abeta-mediated pathology. Cell Death Differ 20, 630-638.
69. Dursun E, Gezen-Ak D, Yilmazer S (2011) A novel perspective for Alzheimer's disease: Vitamin D receptor suppression by amyloid-beta and preventing the amyloidbeta induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 23, 207-219.
70. Dursun E, Gezen-Ak D, Yilmazer S (2013) A new mechanism for amyloid-beta induction of iNOS: Vitamin D-VDR pathway disruption. J Alzheimers Dis 36, 459-474.
71. Annweiler C, Brugg B, Peyrin JM, Bartha R, Beauchet O (2014) Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol Aging 35, 331-335.
72. Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O (2006) Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging. Cell Calcium 40, 277-286.
73. Salami M, Talaei SA, Davari S, TaghizadehM(2012) Hippocampal long term potentiation in rats under different regimens of vitamin D: An in vivo study. Neurosci Lett 509, 56-59.
74. Taghizadeh M, Talaei SA, Djazayeri A, Salami M (2014) Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer's disease. Nutr Neurosci 17, 172-177.
75. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21, 98-108.
76. Zhu Y, Zhou R, Yang R, Zhang Z, Bai Y, Chang F, Li L, Sokabe M, Goltzman D, Miao D, Chen L (2012) Abnormal neurogenesis in the dentate gyrus of adult mice lacking 1,25-dihydroxy vitamin D3 (1,25-(OH)2 D3). Hippocampus 22, 421-433.
77. Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, Boucraut J, Mackay-Sim A, McGrath J, Feron F (2007) Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics 7, 769-780.
78. Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, McGrath J, Feron F (2007) Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 103, 538-545.
79. Nissou MF, Brocard J, El Atifi M, Guttin A, Andrieux A, Berger F, Issartel JP, Wion D (2013) The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases. J Alzheimers Dis 35, 553-564.
80. Nissou MF, Guttin A, Zenga C, Berger F, Issartel JP,Wion D(2014) Additional clues for a protective role of vitaminD in neurodegenerative diseases: 1,25-dihydroxyvitamin D3 triggers an anti-inflammatory response in brain pericytes. J Alzheimers Dis 42, 789-799.
81. Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21, 6480-6491.
82. Brown GC (2007) Nitric oxide and mitochondria. Front Biosci 12, 1024-1033.
83. BrownGC, BorutaiteV(2001) Nitric oxide, mitochondria, and cell death. IUBMB Life 52, 189-195.
84. Keeney JT, Forster S, Sultana R, Brewer LD, Latimer CS, Cai J, Klein JB, Porter NM, Butterfield DA (2013) Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: Implications for low vitamin D-dependent age-related cognitive decline. Free Radic Biol Med 65, 324-334.
85. Lefebvre d'Hellencourt C, Montero-Menei CN, Bernard R, Couez D (2003) Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res 71, 575-582.
86. Garcion E, Sindji L, Montero-Menei C, Andre C, Brachet P, Darcy F (1998) Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25-dihydroxyvitamin D3. Glia 22, 282-294.
87. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170, 5382-5390.
88. Lue LF, Kuo YM, Beach T, Walker DG (2010) Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol 41, 115-128.
89. Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M,Weitzman R, HaydenEY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB (2013) 1alpha,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer's disease patients. J Alzheimers Dis 34, 155-170.
90. Lee V, Rekhi E, Hoh Kam J, Jeffery G (2012) Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging 33, 2382-2389.
91. Mizwicki MT, Menegaz D, Zhang J, Barrientos-Duran A, Tse S, Cashman JR, Griffin PR, Fiala M (2012) Genomic and nongenomic signaling induced by 1alpha,25(OH)2-vitamin D3 promotes the recovery of amyloid-beta phagocytosis by Alzheimer's disease macrophages. J Alzheimers Dis 29, 51-62.
92. Luong KV, Nguyen LT (2013) The role of vitamin d in autoimmune hepatitis. J Clin Med Res 5, 407-415.
93. Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O (2011) Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: A 7-year longitudinal study. Dement Geriatr Cogn Disord 32, 273-278.
94. Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O (2012) Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: A 7-year follow-up. J Gerontol A Biol Sci Med Sci 67, 1205-1211.
95. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O (2010) Association of vitaminDdeficiency with cognitive impairment in older women: Cross-sectional study. Neurology 74, 27-32.
96. Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beauchet O (2010) Dietary intake of vitamin D and cognition in olderwomen:Alarge population-based study. Neurology 75, 1810-1816.
97. Slinin Y, Paudel M, Taylor BC, Ishani A, Rossom R, Yaffe K, Blackwell T, Lui LY, Hochberg M, Ensrud KE (2012) Association between serum 25(OH) vitaminDand the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 67, 1092-1098.
98. Rossom RC, Espeland MA, Manson JE, Dysken MW, Johnson KC, Lane DS, LeBlanc ES, Lederle FA, Masaki KH, Margolis KL (2012) Calcium and vitamin D supplementation and cognitive impairment in thewomen's health initiative. J Am Geriatr Soc 60, 2197-2205.
99. Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Canales MT, Yaffe K, Barrett-Connor E, Orwoll ES, Shikany JM, Leblanc ES, Cauley JA, Ensrud KE (2010) 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 74, 33-41.
100. Afzal S, Bojesen SE, Nordestgaard BG (2014) Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia. Alzheimers Dement 10, 296-302.
101. Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O (2012) Vitamin D insufficiency and mild cognitive impairment: Cross-sectional association. Eur J Neurol 19, 1023-1029.
102. Buell JS, Scott TM,Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL (2009) Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 64, 888-895.
103. Jorde R, Mathiesen EB, Rogne S, Wilsgaard T, Kjaergaard M, Grimnes G, Schirmer H (2015) Vitamin D and cognitive function: The Tromso Study. J Neurol Sci 355, 155-161.
104. Leedahl DD, Cunningham JL, Drake MT, Mundis CB, Kung S, Frye MA, Lapid MI (2013) Hypovitaminosis D in psychiatric inpatients: Clinical correlation with depressive symptoms, cognitive impairment, and prescribing practices. Psychosomatics 54, 257-262.
105. Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83, 920-928.
106. Llewellyn DJ, Lang IA, Langa KM, Melzer D (2011) Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 66, 59-65.
107. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170, 1135-1141.
108. Llewellyn DJ, Langa KM, Lang IA (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22, 188-195.
109. Maddock J, Geoffroy MC, Power C, Hypponen E (2014) 25-Hydroxyvitamin D and cognitive performance in midlife. Br J Nutr 111, 904-914.
110. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic D (2007) No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 29, 49-54.
111. Seamans KM, Hill TR, Scully L, Meunier N, Andrillo-Sanchez M, Polito A, Hininger-Favier I, Ciarapica D, Simpson EE, Stewart-Knox BJ, O'Connor JM, Coudray C, Cashman KD (2010) Vitamin D status and measures of cognitive function in healthy older European adults. Eur J Clin Nutr 64, 1172-1178.
112. Tolppanen AM, Sayers A, Fraser WD, Lawlor DA (2012) Association of serum 25-hydroxyvitamin D(3) and D(2) with academic performance in childhood: Findings from a prospective birth cohort. J Epidemiol Community Health 66, 1137-1142.
113. Tolppanen AM, Williams D, Lawlor DA (2011) The association of circulating 25-hydroxyvitamin D and calcium with cognitive performance in adolescents: Crosssectional study using data from the third National Health and Nutrition Examination Survey. Paediatr Perinat Epidemiol 25, 67-74.
114. Tolppanen AM, Williams DM, Lawlor DA (2011) The association of serum ionized calcium and vitamin D with adult cognitive performance. Epidemiology 22, 113-117.
115. Annweiler C, Fantino B, Gautier J, Beaudenon M, Thiery S, Beauchet O (2012) Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: A pre-post study. J Am Geriatr Soc 60, 793-795.
116. Annweiler C, Herrmann FR, Fantino B, Brugg B, Beauchet O (2012) Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: A pre-post pilot study. Cogn Behav Neurol 25, 121-127.
117. Corless D, Dawson E, Fraser F, Ellis M, Evans SJ, Perry JD, Reisner C, Silver CP, Beer M, Boucher BJ, et al. (1985) Do vitamin D supplements improve the physical capabilities of elderly hospital patients? Age Ageing 14, 76-84.
118. Dean AJ, Bellgrove MA, Hall T, Phan WM, Eyles DW, Kvaskoff D, McGrath JJ (2011) Effects of vitamin D supplementation on cognitive and emotional functioning in young adults-a randomised controlled trial. PLoS One 6, e25966.
119. Dhesi JK, Jackson SH, Bearne LM, Moniz C, HurleyMV, Swift CG, Allain TJ (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33, 589-595.
120. Przybelski R, Agrawal S, Krueger D, Engelke JA,Walbrun F, Binkley N (2008) Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19, 1621-1628.
121. Stein MS, Scherer SC, Ladd KS, Harrison LC (2011) A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis 26, 477-484.
122. Etgen T, Sander D, Bickel H, Sander K, Forstl H (2012) VitaminDdeficiency, cognitive impairment and dementia: A systematic review and meta-analysis. Dement Geriatr Cogn Disord 33, 297-305.
123. van der Schaft J, Koek HL, Dijkstra E, Verhaar HJ, van der Schouw YT, Emmelot-Vonk MH (2013) The association between vitamin D and cognition: A systematic review. Ageing Res Rev 12, 1013-1023.
124. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P (2012) Vitamin D, cognition, and dementia: A systematic review and metaanalysis. Neurology 79, 1397-1405.
125. Annweiler C, Llewellyn DJ, Beauchet O (2013) Low serum vitamin D concentrations in Alzheimer's disease: A systematic review and meta-analysis. J Alzheimers Dis 33, 659-674.
126. Annweiler C, Fantino B, Le Gall D, Schott AM, Berrut G, Beauchet O (2011) Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J Am Geriatr Soc 59, 169-171.
127. Tot Babberich Ede N, Gourdeau C, Pointel S, Lemarchant B, Beauchet O, Annweiler C (2015) Biology of subjective cognitive complaint amongst geriatric patients: Vitamin D involvement. Curr Alzheimer Res 12, 173-178.
128. Schram MT, Trompet S, Kamper AM, de Craen AJ, Hofman A, Euser SM, Breteler MM, Westendorp RG (2007) Serum calcium and cognitive function in old age. J Am Geriatr Soc 55, 1786-1792.
129. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE (2004) Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 59, 268-274.
130. Annweiler C, BeauchetO(2013)VitaminDand cognition: Recommendations for future trials. J Am Geriatr Soc 61, 1049-1050.
131. Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O (2013) Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 37, 147-171.
132. Crombie I (1996) The Pocket Guide to Critical Appraisal, BMJ Publishing Group, London, England.
133. Annweiler C, Maby E, Meyerber M, Beauchet O (2014) Hypovitaminosis D and executive dysfunction in older adults with memory complaint: A memory clinic-based study. Dement Geriatr Cogn Disord 37, 286-293.
134. Cui X, Gooch H, Groves NJ, Sah P, Burne TH, Eyles DW, McGrath JJ (2015)VitaminDand the brain:Key questions for future research. J Steroid Biochem Mol Biol 148, 305-309.
135. Blair JA, McGee H, Bhatta S, Palm R, Casadesus G (2015) Hypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: More than "just" estrogen. Front Endocrinol (Lausanne) 6, 45.
136. Lan YL, Zhao J, Li S (2015) Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease. J Alzheimers Dis 43, 1137-1148.
137. Li R, Cui J, Shen Y (2014) Brain sex matters: Estrogen in cognition and Alzheimer's disease. Mol Cell Endocrinol 389, 13-21.
138. Bikle D (2000) Vitamin D: Production, metabolism, and mechanisms of action. In Endotext, De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, eds. South Dartmouth (MA).
139. Johansson P, Almqvist EG, Johansson JO, Mattsson N, Andreasson U, Hansson O, Wallin A, Blennow K, Zetterberg H, Svensson J (2013) Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease. PLoS One 8, e81989.
140. Ryynanen J, Neme A, Tuomainen TP, Virtanen JK, Voutilainen S, Nurmi T, de Mello VD, Uusitupa M, Carlberg C (2014) Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Mol Nutr Food Res 58, 2036-2045.
141. Blanchard OL, Smoliga JM (2015) Translating dosages from animal models to human clinical trials-revisiting body surface area scaling. FASEB J 29, 1629-1634.
142. Schwartz JB, Kane L, Bikle D (2016) Response of vitamin D concentration to vitamin D3 administration in older adults without sun exposure: A randomized double-blind trial. J Am Geriatr Soc 64, 65-72.
143. Annweiler C, BeauchetO(2014)Vitamin d in older adults: The need to specify standard values with respect to cognition. Front Aging Neurosci 6, 72.